Behaviour of Cell Lines in a Selection Strategy
|
|
- June Dennis
- 7 years ago
- Views:
Transcription
1 Cell Line Development and Engineering 27 Behaviour of Cell Lines in a Selection Strategy Alison Porter, Lonza Biologics plc, Slough, GB, 6 March 27
2 Scope of Talk Cell line construction Issues and Requirements Current cell line construction strategy Challenging the current cell line selection strategy slide 2
3 Cell Line Construction Issues and Requirements
4 Cell Line Construction Issues and Requirements Issue: Transfection results in heterogeneous population Measurements made early in construction of a cell line may not reflect how it behaves in the final production process Requirement: Selection of cell lines with appropriate specific production rates (Q P ) and growth characteristics slide 4
5 Cell Line Construction Issues and Requirements A possible strategy Take large numbers (possibly thousands) of cell lines through to the final production process Scientifically sound Lengthy and resource intensive Developing other strategies Designed with reference to the final production process Requires prediction of manufacturing behaviour of cell lines at very early stage Economic Compatible with resources slide 5
6 Cell Line Construction Objectives Objective of any cell line selection strategy is to isolate cell line(s) that: Are high volumetric producers Show acceptable growth in final inoculum processes Show desired product quality Including bioactivity slide 6
7 Current Cell Line Construction Strategy
8 Current Cell Line Construction Strategy Vectors designed to promote expression of the gene(s) of interest (GOIs) Strong promoter (hcmv) drives expression of the GOIs Weak promoter (SV4) on GS gene is coupled with selection in high (stringent) levels of MSX selects for integration at transcriptionally active loci GOIs and GS gene are on the same plasmid and tightly linked Integration of GS gene into transcriptionally active loci results in co-integration of GOIs into same loci slide 8
9 Current GS-CHO Cell Line Construction Method Transfect CHOK1SV host cells with vector 96-well plates, single colonies per well Static culture - CDACF medium 2 3 cell lines Semi-quantitative productivity assessment 1-15 cell lines Quantitative productivity assessment 3 6 cell lines Suspension (shake-flask) culture - CDACF medium Select cell lines for stability assessment 5-1 cell lines Adapt to suspension culture 3 6 cell lines Preliminary quantitative assessment Select cell lines to clone Fed-batch assessment of growth, productivity and product quality slide 9
10 Fed-Batch Shake-Flask Screen of GS-CHO Cell Lines Product Concentration (mg/l) Q P (pg/cell/hour) Antibody 2 Antibody IVC (1 6 cells.h/ml) Max X V (1 6 cells/ml) Antibody Antibody slide 1
11 Batch and Fed-Batch Culture: Comparison of Ranking Positions Examples from two GS-CHO construction programmes Rank Position Rank Position Preliminary Productivity Assessment Scale-down Model of the Final Production Process Individual cell lines respond differently to feed Change in rank position 2 Preliminary Productivity Assessment Scale-down Model of the Final Production Process slide 11
12 Fed-Batch Shake-Flask vs. Fed-Batch Bioreactor 3 Value in Bioreactor Relative to Shake-Flask Product Concentration Parameter Relationship between productivity characteristics of the lead GS-CHO cell lines making ten different antibodies Individual cell lines respond differently to culture in bioreactors Q P slide 12
13 Current Cell Line Construction Strategy - Summary Individual cell lines respond differently to environment Feed Bioreactor Suggests requirement for more powerful strategies for selecting best cell lines A better model of the bioreactor likely to be a key requirement slide 13
14 Challenging The Current Cell Line Selection Strategy
15 Challenging The Current Cell Line Construction Strategy Objective: to increase the frequency of isolating the best 5% of cell lines With no change in resource requirement or elapsed time Potential issue High producing cell lines are isolated using the current cell line construction strategy Are these good cell lines rather than the best cell lines? Lowest producers discarded at each stage and response of cells to environment differs. Limitations with assessment of available data Initial work to fully understand what happens in current selection strategy may therefore help fulfil the objective slide 15
16 Challenging The Current Cell Line Construction Strategy Hypothesis: A screen stage fully predicts the behaviour of the cell lines in the subsequent screens Is any screen truly predictive? At each stage cell line(s) are discarded/selected which do/don t do well in a particular system How? Progression of 175 randomly selected cell lines from transfection through all selection stages prior to fermentation Assessment of a subset of these in bioreactors slide 16
17 Challenging The Current Cell Line Selection Strategy - Method Transfect CHOK1SV host cells with vector 96-well plates, single colonies per well 175 cell lines Semi-quantitative productivity assessment spot Static culture - CDACF medium 175 cell lines Quantitative productivity assessment 24-well plate 175 cell lines Suspension (shake-flask) culture - CDACF medium Adapt to suspension culture Bioreactor assessment 175 cell lines 175 cell lines Preliminary quantitative assessment batch Pseudo-random selection of 29 cell lines for bioreactors Fed-batch assessment slide 17
18 Challenging The Current Cell Line Selection Strategy Productivity Results Specific Activity Spot Product Concentration (mg/l) well plate Product Concentration (mg/l) Batch Cell Line Product Concentration (mg/l) Fed-batch Cell Line Cell Line Cell Line slide 18
19 Challenging The Current Cell Line Selection Strategy Location of Selected Top 1 Current selection strategy used to identify top 1 cell lines from the 175 cell lines Spot : cell lines 24-well plate : 12 6 cell line Batch : 6 1 cell lines These cell lines designated the selected top 1 Would progress to assessment in fed-batch screen Where are these ten cell lines at each screen stage? slide 19
20 Specific Activity Challenging The Current Cell Line Selection Strategy Location of Selected Top 1 Spot Product Concentration (mg/l) well plate Product Concentration (mg/l) Batch Cell Line Product Concentration (mg/l) Fed-batch Cell Line Cell Line Cell Line slide 2
21 Challenging The Current Cell Line Selection Strategy Location of selected Top 1 Use of the selection strategy has not resulted in the selection of the top ten highest producers at the fed-batch stage Where are the real top ten cell lines at each stage? Location of the ten highest producers identified in the fed-batch screen What happens if screen stages are missed out? slide 21
22 Specific Activity Challenging The Current Cell Line Selection Strategy Location of the Real Top 1 Spot Product Concentration (mg/l) well plate Product Concentration (mg/l) Batch Cell Line Product Concentration (mg/l) Fed-batch Cell Line Cell Line Cell Line slide 22
23 Challenging The Current Cell Line Selection Strategy Removal of Screen Stages Product Concentration (mg/l) Selected top ten Product Concentration (mg/l) Assessing spot data only Product Concentration (mg/l) Cell Line Removing the 24-well plate screen Product Concentration (mg/l) Cell Line Removing the batch screen Cell Line Cell Line slide 23
24 Challenging The Current Cell Line Selection Strategy Cell Line Locations Summary Use of the current selection strategy does result in the selection of highly productive cell lines Use of the current selection strategy does not result in the selection of all ten cell lines which are the highest producers in the fed-batch screen It is possible to discard cell lines which would be high producers Use of the spot screen alone is not sufficient to identify a high producing cell line May be possible to have just the 24-well plate or batch screen stage rather than both? Could then refocus resource on the fed-batch screen Further statistical analysis is in progress to investigate this slide 24
25 Challenging The Current Cell Line Selection Strategy Ranking Progress to examine whether ranking position of cell line changes between each screen Are the screens truly predictive? slide 25
26 Challenging The Current Cell Line Selection Strategy Ranking -2 High ranking Rank Position 'spot' '24-well plate' 'batch' 'fed-batch' Low ranking slide 26
27 Challenging The Current Cell Line Selection Strategy Ranking -2 High ranking Rank Position 'spot' '24-well plate' 'batch' 'fed-batch' Low ranking slide 27
28 Challenging The Current Cell Line Selection Strategy Ranking Ranking position of a cell line can change as it moves through the different screens Movement both up and down can be observed Those cell lines which are initially the lowest producers tend to remain as low producers throughout each screen Is the ranking position in one screen predictive of the ranking position in the next screen? slide 28
29 Challenging The Current Cell Line Selection Strategy Contingency Tables 4 4 Number of Cell Lines Quartile in 'spot' Quartile in '24- Well Plate' Number of Cell Lines Quartile in '24-Well Plate' Quartile in 'Batch' Initial statistical analysis suggests there is a relationship between variables Number of Cell Lines Quartile in 'Batch' Quartile in 'Fed- Batch' Propose that this relationship primarily due to those which are low producers tending to remain low producers through each screen slide 29
30 Challenging The Current Cell Line Selection Strategy Bioreactor Results A subset of the 175 cell lines were assessed in 1 L bioreactors 29 cell lines assessed How do results in shake-flasks compare to results in bioreactors for these cell lines? slide 3
31 Bioreactor: Product Concentration (mg/l) Bioreactor: IVC (1 6 cells/ml.h) Challenging The Current Cell Line Selection Strategy Bioreactor Results Shake-flask: Product Concentration (mg/l) Shake-Flask: IVC (1 6 cells/ml.h) Bioreactor: Q P (pch) Shake-Flask: Q P (pch) Positive correlation between shake-flask and bioreactor results for: Product concentration (r =.86, p =.5) Q P (r =.94, p =.5) IVC (r =.46, p =.5) slide 31
32 Challenging The Current Cell Line Selection Strategy Bioreactor Results Selected top ten highlighted: Bioreactor: Product Concentration (mg/l) Changes in rank position observed Shake-flask: Product Concentration (mg/l) A cell line which is highly productive in the final production process can be selected It may not be the highest producer slide 32
33 Challenging The Current Cell Line Selection Strategy Bioreactor Results There is positive correlation between results obtained in shake-flasks and bioreactors for productivity characteristics and for IVC Seen for a range of productivities Rank positions may change between shake-flasks and bioreactors Although prediction of the highest producer in the bioreactor did not occur, a high producing cell line was still identified slide 33
34 Challenging The Current Cell Line Selection Strategy Summary Variation in measured parameters observed at each assessment stage Ranking positions not consistent as cell lines progress through the different assessment stages Heterogeneous response of cell lines to environment Cell lines which would exhibit good characteristics in the final production process can be discarded during the selection strategy Fed-batch shake-flask screen not truly predictive of behaviour in bioreactor Reject the hypothesis that any screen fully predicts the behaviour in subsequent screens However, use of the current selection strategy still enables identification of highly productive cell lines slide 34
35 Challenging The Current Cell Line Selection Strategy Summary Initial statistical analysis does suggest a relationship between the screens Low producers tend to remain low producers slide 35
36 Challenging The Current Cell Line Selection Strategy Discussion Possible reasons for why each assessment stage is not truly predictive of the next: Loss of GOI A cell line which is high producing at one screen and then low producing at the rest Pseudo-random integration of the integrated genes throughout the genome Susceptibility of loci to epigenetic affects Affect of loci on mrna transport Affect of loci on functioning of other genes in adjacent areas slide 36
37 Challenging The Current Cell Line Selection Strategy The future As current selection strategy is not truly predictive of behaviour in final selection strategy, there is an opportunity to improve the selection strategy Statistical analysis to determine how many cell lines to screen at each stage to increase frequency of identification of best 5% cell lines Remove a screen stage and refocus resource onto one of the other screen stages? Screen more cell lines at the later stages? Develop more predictive early assessments? Although not necessarily the best cell lines, very good cell lines can be isolated in the current selection strategy slide 37
38 Acknowledgements Lonza Biologics plc, Slough, GB Andy Racher Juanita Porter Atul Mohindra Emma Allen Tracy Root Eric Le Guern Richard Aldcroft Cell Culture Process Development Group Analytical Development Group University of Manchester Alan Dickson Louise Barnes slide 38
Improving GS-CHO Cell Line Selection: Reducing Time to Clinic
Cell Line Development and Engineering 2-6 March 2009, Berlin Improving GS-CHO Cell Line Selection: Reducing Time to Clinic Adrian Haines, 2009 Lonza Biologics plc, Slough, UK Disclaimer Certain matters
More informationESTABLISHMENT OF CELL LINES FOR MANUFACTURING RECOMBINANT ANTIBODIES. Dr Andrew Racher
ESTABLISHMENT OF CELL LINES FOR MANUFACTURING RECOMBINANT ANTIBODIES Dr Andrew Racher Lonza Biologics plc, 2004 Structure of talk Issues Selection of a high producing cell line Selection for process compatibility
More informationThe Importance of Developing a High Yield of Product
European Antibody Congress Lyon, 3 rd November 2005 The Importance of Developing a High Yield of Product John Birch, Lonza Biologics plc Monoclonal Antibodies A Success Story Fastest growing segment of
More informationSelection of Cell Lines for Manufacturing Therapeutic Antibodies by Flow Cytometric Cell Sorting. Andrew Racher Lonza Biologics
Selection of Cell Lines for Manufacturing Therapeutic Antibodies by Flow Cytometric Cell Sorting Andrew Racher Lonza Biologics Structure of Talk 1. The Problem 2. Possible Solutions 3. Solution Chosen
More informationAccelerating Antibody Process Development: Exploring the Synergies Between Engineered Host Cells and Process Development
Pharma&Biotech Accelerating Antibody Process Development: Exploring the Synergies Between Engineered Host Cells and Process Development James Rance PhD Head of Development Services Singapore Lonza Biologics
More informationHow To Develop A Cell Line
Advances in The Development of Biopharmaceuticals The application of modern technologies and services to the development of Biopharmaceutical processes Dr Jonathan H Dempsey Process Science Fellow Invitrogen
More informationPotelligent CHOK1SV. European Antibody Congress 30 Nov - 02 Dec, Geneva, Switzerland. Alison Porter, 2009 Lonza Biologics plc, Slough, UK
Potelligent European Antibody Congress 30 Nov - 02 Dec, Geneva, Switzerland Alison Porter, 2009 Lonza Biologics plc, Slough, UK Disclaimer Certain matters discussed in this presentation may constitute
More informationImportant Topics in the Expression of Recombinant Antibodies from CHO Cells
Cell Line Development and Engineering Workshop, Prague, March 2008 Important Topics in the Expression of Recombinant Antibodies from CHO Cells Robert Young/Lonza Biologics/Mar 2008 Disclaimer Certain matters
More informationHigh yield antibody production in a disposable WAVE Bioreactor
High yield antibody production in a Process intensification using perfusion culture Christian Kaisermayer 1, Jianjun Yang 2 1 GE Healthcare Europe GmbH, Vienna, Austria (Christian.Kaisermayer@ge.com),
More informationBioProcessing J O U R N A L. Trends and Developments in BioProcess Technology. Volume 9 Issue 1 ISSN 1538-8786
A Production of ISBioTech Summer 2010 Issue BioProcessing J O U R N A L Trends and Developments in BioProcess Technology Volume 9 Issue 1 ISSN 1538-8786 Trends & Developments in BioProcess Technology Novel
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS
More informationA customizable ADCC assay service for antibodies & fusion proteins.
Antibody Dependent Cell- Mediated Cytotoxicity (ADCC) Assay A customizable ADCC assay service for antibodies & fusion proteins. Our ADCC assay service accurately detects cell lysis based on LDH-release.
More informationAccelerating drug development to FTIH: Potential of new expression technologies
Accelerating drug development to FTIH: Potential of new expression technologies Lekan Daramola Associate Director Biopharmaceutical Development, Cell Culture & Fermentation Sciences CMC Strategy Forum
More informationEuropean Medicines Agency
European Medicines Agency July 1996 CPMP/ICH/139/95 ICH Topic Q 5 B Quality of Biotechnological Products: Analysis of the Expression Construct in Cell Lines Used for Production of r-dna Derived Protein
More informationLuca Romagnoli, Ph.D. Business Development Manager
Modelli innovativi di produzione per lo sviluppo di un processo altamente qualitativo di farmaci biologici Luca Romagnoli, Ph.D. Business Development Manager BIOLOGICAL DRUGS - SOURCES Monoclonal antibodies
More informationCell Culture Technology for Pharmaceutical and Cellular Therapies
Cell Culture Technology for Pharmaceutical and Cellular Therapies Sadettin S. Ozturk, Ph.D. Centocor Inc. 200 Great Valley Parkway, Malvern, PA 19355 Outline 1. Introduction to Monoclonal Antibodies 2.
More informationTHE PREDICTIVE MODELLING PROCESS
THE PREDICTIVE MODELLING PROCESS Models are used extensively in business and have an important role to play in sound decision making. This paper is intended for people who need to understand the process
More informationOriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation
OriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation -Optimal strategies to a successful mirna research project Optimal strategies to a successful mirna research
More informationEMABling Antibody Production Platform
EMABling Antibody Production Platform An industrial solution for the production of therapeutic antibodies with high cytotoxic activity B IOMANUFACTURING EMABling : A fully integrated development platform
More informationAnimal Cell Culture. Third Edition. A Practical Approach OXJORD VNIVVRSITY 1'RVSS
Animal Cell Culture Third Edition A Practical Approach Edited by John R. W. Masters 3rd Floor Research Laboratories, University College London OXJORD VNIVVRSITY 1'RVSS Contents List of protocols page xiii
More informationLFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB
More informationInvestigating the genetic basis for intelligence
Investigating the genetic basis for intelligence Steve Hsu University of Oregon and BGI www.cog-genomics.org Outline: a multidisciplinary subject 1. What is intelligence? Psychometrics 2. g and GWAS: a
More informationLFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB
More informationLearning Predictive Models of Gene Dynamics. Nick Jones, Sumeet Agarwal
Learning Predictive Models of Gene Dynamics Nick Jones, Sumeet Agarwal An Aim of Systems Biology How about predicting what cells are going to do? Quantitatively predict the response of cells to multiple
More informationrestriction enzymes 350 Home R. Ward: Spring 2001
restriction enzymes 350 Home Restriction Enzymes (endonucleases): molecular scissors that cut DNA Properties of widely used Type II restriction enzymes: recognize a single sequence of bases in dsdna, usually
More informationExciting Trends in Bioprocessing
Exciting Trends in Bioprocessing Alfred Doig and Susan Dana Jones, Ph.D. April 20, 2015 BioProcess Technology Consultants, Inc. 12 Gill Street, Suite 5450 Woburn, MA 01801 Exciting Trends in Bioprocessing
More informationValentina Gualato, Ph.D. Process Development Scientist
COMPANY PRESENTATION Quality and Innovation Valentina Gualato, Ph.D. Process Development Scientist MISSION areta international is a biotech company dedicated to the contract development and manufacturing
More informationGeneral Properties Protein Nature of Enzymes Folded Shape of Enzymes H-bonds complementary
Proteins that function as biological catalysts are called enzymes. Enzymes speed up specific metabolic reactions. Low contamination, low temperature and fast metabolism are only possible with enzymes.
More informationApplication Note USD3013. Monoclonal Antibody Production in Suspension CHO Culture Using Single-Use PadReactor Mini Bioreactor
Application Note USD313 Monoclonal Antibody Production in Suspension CHO Culture Using Single-Use PadReactor Mini Bioreactor Introduction Single use solutions are found in many applications as they offer
More informationBACTERIAL ENUMERATION
BACTERIAL ENUMERATION In the study of microbiology, there are numerous occasions when it is necessary to either estimate or determine the number of bacterial cells in a broth culture or liquid medium.
More informationTesting Metrics. Introduction
Introduction Why Measure? What to Measure? It is often said that if something cannot be measured, it cannot be managed or improved. There is immense value in measurement, but you should always make sure
More informationAnswer Key Problem Set 5
7.03 Fall 2003 1 of 6 1. a) Genetic properties of gln2- and gln 3-: Answer Key Problem Set 5 Both are uninducible, as they give decreased glutamine synthetase (GS) activity. Both are recessive, as mating
More informationMolecular Biology Techniques: A Classroom Laboratory Manual THIRD EDITION
Molecular Biology Techniques: A Classroom Laboratory Manual THIRD EDITION Susan Carson Heather B. Miller D.Scott Witherow ELSEVIER AMSTERDAM BOSTON HEIDELBERG LONDON NEW YORK OXFORD PARIS SAN DIEGO SAN
More informationTriskel: a strategic consulting firm for biopharmaceutical companies
BioStart : Manufacturing and operations in Biotech Strategic stakes and technology evolution in recombinant protein production APFL May 14 th, 2009 François LAWNY Triskel Integrated Services Geneva, Switzerland
More informationObserving and describing the behavior of a subject without influencing it in any way.
HOW TO CHOOSE FROM THE DIFFERENT RESEARCH METHODS* The design is the structure of any scientific work. It gives direction and systematizes the research. The method you choose will affect your results and
More informationAmaxa Mouse T Cell Nucleofector Kit
Amaxa Mouse T Cell Nucleofector Kit For T cells isolated from C57BL/6 & BALB/c mice Evaluated for murine T cells isolated from C57BL/6 & BALB/c mice This protocol is designed for murine lymphocytes or
More informationDr.ssa Maria Luisa Nolli CEO
IL RUOLO DELLE PICCOLE E MEDIE INDUSTRIE NELLA PROMOZIONE DELLA MEDICINA TRASLAZIONALE Quality and Innovation Dr.ssa Maria Luisa Nolli CEO INTRODUCTION ARETA INTERNATIONAL 12 years of experience in contract
More informationDescriptive Statistics
Descriptive Statistics Primer Descriptive statistics Central tendency Variation Relative position Relationships Calculating descriptive statistics Descriptive Statistics Purpose to describe or summarize
More informationINTERFERin in vitro sirna/mirna transfection reagent PROTOCOL. 1 Standard sirna transfection of adherent cells... 2
INTERFERin in vitro sirna/mirna transfection reagent PROTOCOL DESCRIPTION INTERFERin is a powerful sirna/mirna transfection reagent that ensures efficient gene silencing and reproducible transfection in
More informationProcess Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle
Process Performance Qualification Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle A LIFECYCLE Approach to Process Validation? Lifecycle [ICH Q8(R2)]: All phases
More informationMOL.911 HNL Expression
1 W I S S E N T E C H N I K L E I D E N S C H A F T MOL.911 HNL Expression www.tugraz.at 2 Hydroxynitrile lyase (Hnl) R 1 HCN R 1 OH R 2 C O R 2 C * CN S selective: Hevea brasiliensis R selective: Prunus
More informationIntegrated Protein Services
Integrated Protein Services Custom protein expression & purification Last date of revision June 2015 Version DC04-0013 www.iba-lifesciences.com Expression strategy The first step in the recombinant protein
More informationA role of microrna in the regulation of telomerase? Yuan Ming Yeh, Pei Rong Huang, and Tzu Chien V. Wang
A role of microrna in the regulation of telomerase? Yuan Ming Yeh, Pei Rong Huang, and Tzu Chien V. Wang Department of Molecular and Cellular Biology, Chang Gung University, Kwei San, Tao Yuan 333, Taiwan
More informationWhy Taking This Course? Course Introduction, Descriptive Statistics and Data Visualization. Learning Goals. GENOME 560, Spring 2012
Why Taking This Course? Course Introduction, Descriptive Statistics and Data Visualization GENOME 560, Spring 2012 Data are interesting because they help us understand the world Genomics: Massive Amounts
More informationGRS Plasmid Purification Kit Transfection Grade GK73.0002 (2 MaxiPreps)
1 GRS Plasmid Purification Kit Transfection Grade GK73.0002 (2 MaxiPreps) (FOR RESEARCH ONLY) Sample : Expected Yield : Endotoxin: Format : Operation Time : Elution Volume : 50-400 ml of cultured bacterial
More informationSecretion Assay Cell Screening Service Gel Microdrop
Cell Screening Service Gel Microdrop The Cell Screening Service is comprised of five phases: 1) Evaluation of the Cell Line after encapsulation; 2) Assessment of Reagents; 3) Secretion Assay Optimization;
More informationHow to Measure a Loyalty Programme s Return on Investment. Managing information and transactions securely
How to Measure a Loyalty Programme s Return on Investment Managing information and transactions securely Introduction Successful programmes have longevity because the overall benefits clearly justify the
More informationChemistry 2351: Inorganic Chemistry I Laboratory Manual
Spectroscopic Determination of a Complex Ion's Stoichiometry by Job's Method ABSTRACT This experiment is adapted from Angelici's classic experiment, but uses Fe(H 2 O) 6-n (SCN) n 3-n as the complex ion.
More informationDETECTION OF BACTERIAL MOTILITY. To demonstrate bacterial motility by microscopic and macroscopic techniques.
DETECTION OF BACTERIAL MOTILITY I. OBJECTIVES To demonstrate bacterial motility by microscopic and macroscopic techniques. To observe flagella in prepared slides stained by specific flagellar stains. II.
More informationSTOP. Before using this product, please read the Limited Use License statement below:
STOP Before using this product, please read the Limited Use License statement below: Important Limited Use License information for pdrive5lucia-rgfap The purchase of the pdrive5lucia-rgfap vector conveys
More informationHCS604.03 Exercise 1 Dr. Jones Spring 2005. Recombinant DNA (Molecular Cloning) exercise:
HCS604.03 Exercise 1 Dr. Jones Spring 2005 Recombinant DNA (Molecular Cloning) exercise: The purpose of this exercise is to learn techniques used to create recombinant DNA or clone genes. You will clone
More informationSURVEY DESIGN: GETTING THE RESULTS YOU NEED
SURVEY DESIGN: GETTING THE RESULTS YOU NEED Office of Process Simplification May 26, 2009 Sarah L. Collie P. Jesse Rine Why Survey? Efficient way to collect information about a large group of people Flexible
More informationQuantitative Software Management
Quantitative Software Management The Impact of Team Size on Software Project Productivity Donald M. Beckett QSM, Inc. 2000 Corporate Ridge, Suite 900 McLean, VA 22102 (360) 697-2640, fax: (703) 749-3795
More informationGuideline for Generation of Stable Cell Lines Technical Reference Guide
BioResearch Guideline for Generation of Stable Cell Lines Technical Reference Guide 1. Background Stable, long-term expression of a gene of interest can be either achieved by eukaryotic vectors that harbor
More informationTowards energy-based dynamic optimization of monoclonal antibody producing GS-NS0 Cultures
20 th European Symposium on Computer Aided Process Engineering ESCAPE20 S. Pierucci and G. Buzzi Ferraris (Editors) 2010 Elsevier B.. All rights reserved. Towards energy-based dynamic optimization of monoclonal
More informationIntegrated Protein Services
Integrated Protein Services Custom protein expression & purification Version DC04-0012 Expression strategy The first step in the recombinant protein generation process is to design an appropriate expression
More informationThe use of FACS for the selection of cell lines with superior productivity characteristics
ESACT-UK, Cambridge 2007 The use of FACS for the selection of cell lines with superior productivity characteristics Jonathan Welsh Synopsis Why use FACS in bioprocess development Issues regarding use of
More informationValidation and Calibration. Definitions and Terminology
Validation and Calibration Definitions and Terminology ACCEPTANCE CRITERIA: The specifications and acceptance/rejection criteria, such as acceptable quality level and unacceptable quality level, with an
More informationProto col. GoClone Repor ter Construc ts: Sample Protocol for Adherent Cells. Tech support: 877-994-8240. Luciferase Assay System
Luciferase Assay System Proto col GoClone Repor ter Construc ts: Sample Protocol for Adherent Cells LightSwitch Luciferase Assay System GoClone Reporter Assay Workflow Step 1: Seed cells in plate format.
More informationThe course breaks down the Procurement Process into 5 Steps
The course breaks down the Procurement Process into 5 Steps Define Objective Logistics SCM in 5 steps The course breaks down the Procurement Process into 5 Steps Identify opportunities Capture Benefits
More informationVaccine Manufacturing Facilities of the Future. Howard L. Levine, Ph.D. Vaccines Europe London, England December 1 2, 2010
Vaccine Manufacturing Facilities of the Future Howard L. Levine, Ph.D. Vaccines Europe London, England December 1 2, 2010 Challenges in the Production of Vaccines Different technology platforms make it
More informationSix Sigma Acronyms. 2-1 Do Not Reprint without permission of
Six Sigma Acronyms $k Thousands of dollars $M Millions of dollars % R & R Gauge % Repeatability and Reproducibility ANOVA Analysis of Variance AOP Annual Operating Plan BB Black Belt C & E Cause and Effects
More informationSoftware Metrics. Lord Kelvin, a physicist. George Miller, a psychologist
Software Metrics 1. Lord Kelvin, a physicist 2. George Miller, a psychologist Software Metrics Product vs. process Most metrics are indirect: No way to measure property directly or Final product does not
More informationMolecular Genetics: Challenges for Statistical Practice. J.K. Lindsey
Molecular Genetics: Challenges for Statistical Practice J.K. Lindsey 1. What is a Microarray? 2. Design Questions 3. Modelling Questions 4. Longitudinal Data 5. Conclusions 1. What is a microarray? A microarray
More informationSoftware Engineering. Introduction. Software Costs. Software is Expensive [Boehm] ... Columbus set sail for India. He ended up in the Bahamas...
Software Engineering Introduction... Columbus set sail for India. He ended up in the Bahamas... The economies of ALL developed nations are dependent on software More and more systems are software controlled
More informationDescription: Molecular Biology Services and DNA Sequencing
Description: Molecular Biology s and DNA Sequencing DNA Sequencing s Single Pass Sequencing Sequence data only, for plasmids or PCR products Plasmid DNA or PCR products Plasmid DNA: 20 100 ng/μl PCR Product:
More informationQbD based Development and Characterization of a Cell Culture Process for Therapeutic Proteins
QbD based Development and Characterization of a Cell Culture Process for Therapeutic Proteins 2015. 06. 09 Green Cross Corp. Green Cross Research Center Yong Jae Kim (YJKIM@greencross.com) Biologics World
More informationMTH 140 Statistics Videos
MTH 140 Statistics Videos Chapter 1 Picturing Distributions with Graphs Individuals and Variables Categorical Variables: Pie Charts and Bar Graphs Categorical Variables: Pie Charts and Bar Graphs Quantitative
More informationSpecific Challenges in Large-Scale Manufacturing of Peptide as API s Presentation at TIDES Conference, Las Vegas, April 25 29, 2004
Specific Challenges in Large-Scale Manufacturing of Peptide as API s Presentation at TIDES Conference, Las Vegas, April 25 29, 2004 Oleg Werbitzky Slide 2 Agenda Market environment Current manufacturing
More informationHydroxynitrile lyase (Hnl)
Hydroxynitrile lyase (Hnl) R 1 HCN R 1 OH R 2 C O R 2 C * CN S-selective: Hevea brasiliensis R-selective: Prunus spp. (S)-Hnl of Hevea brasiliensis and (R)-Hnl of Prunus amygdalus Hb_Hnl Type II Hnl intracellular
More informationTransIT -2020 Transfection Reagent
Quick Reference Protocol, MSDS and Certificate of Analysis available at mirusbio.com/5400 INTRODUCTION TransIT -2020 Transfection Reagent is a high-performance, animal-origin free, broad spectrum reagent
More informationEnvironmental Monitoring
Environmental Monitoring Purpose of Environmental Monitoring Critical process within the pharmaceutical and biotechnology industries. Determines the microbial and particulate content of cleanroom air and
More informationMGC premier Expression-Ready cdna clones TCH1103, TCM1104, TCR1105, TCB1106, TCH1203, TCM1204, TCR1205, TCB1206, TCH1303, TCM1304, TCR1305
MGC premier Expression-Ready cdna clones TCH1103, TCM1104, TCR1105, TCB1106, TCH1203, TCM1204, TCR1205, TCB1206, TCH1303, TCM1304, TCR1305 The MGC premier Expression-Ready collection has the high quality,
More informationStatistical tests for SPSS
Statistical tests for SPSS Paolo Coletti A.Y. 2010/11 Free University of Bolzano Bozen Premise This book is a very quick, rough and fast description of statistical tests and their usage. It is explicitly
More informationFacility construction and start up for commercial scale manufacturing of monoclonal antibodies - A case study
24 th Interphex, Japan, Technical Conference June 29 th, 2011 Michael Brown Facility construction and start up for commercial scale manufacturing of monoclonal antibodies - A case study Lonza AG Financially
More informationSimplifying Unconstrained Fixed Income Investing
Investment Management Fixed Income Team, July 204 Simplifying Unconstrained Fixed Income Investing Introduction Financial markets fluctuations in recent years and central banks attempts to sustain the
More informationSPE 54005. Copyright 1999, Society of Petroleum Engineers Inc.
SPE 54005 Volatile Oil. Determination of Reservoir Fluid Composition From a Non-Representative Fluid Sample Rafael H. Cobenas, SPE, I.T.B.A. and Marcelo A. Crotti, SPE, Inlab S.A. Copyright 1999, Society
More informationCell Phone Radiation Effects on Cancer. Tyler Barkich Central Catholic High School Grade 11
Cell Phone Radiation Effects on Cancer Tyler Barkich Central Catholic High School Grade 11 Cancer Overview Cancer cells are cells that grow and divide at an irregular, unregulated pace. Apoptosis does
More informationFinancial Risk Management Exam Sample Questions
Financial Risk Management Exam Sample Questions Prepared by Daniel HERLEMONT 1 PART I - QUANTITATIVE ANALYSIS 3 Chapter 1 - Bunds Fundamentals 3 Chapter 2 - Fundamentals of Probability 7 Chapter 3 Fundamentals
More informationHigh deleterious genomic mutation rate in stationary phase of Escherichia coli
Loewe, L et al. (2003) "High deleterious genomic mutation rate in stationary phase of Escherichia coli" 1 High deleterious genomic mutation rate in stationary phase of Escherichia coli Laurence Loewe,
More informationAmerican Statistical Association
American Statistical Association Promoting the Practice and Profession of Statistics ASA Statement on Using Value-Added Models for Educational Assessment April 8, 2014 Executive Summary Many states and
More informationIntroduction to Hypothesis Testing. Hypothesis Testing. Step 1: State the Hypotheses
Introduction to Hypothesis Testing 1 Hypothesis Testing A hypothesis test is a statistical procedure that uses sample data to evaluate a hypothesis about a population Hypothesis is stated in terms of the
More informationUse of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development
Use of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development Authors: Dr Fern Slingsby and Dr Simon Dewar Upstream Process Development FUJIFILM
More informationPRODUCT INFORMATION...
VIROMER RED In vitro plasmid DNA and mrna Standard Transfection PRODUCT INFORMATION... 2 GENERAL... 2 RED OR YELLOW?... 3 PROTOCOL GUIDELINES... 4 GENERAL REMARKS... 4 CELL CULTURE AND PLATING... 4 FORWARD/REVERSE
More informationTransfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.
Transfection Key words: Transient transfection, Stable transfection, transfection methods, vector, plasmid, origin of replication, reporter gene/ protein, cloning site, promoter and enhancer, signal peptide,
More informationCALCULATIONS & STATISTICS
CALCULATIONS & STATISTICS CALCULATION OF SCORES Conversion of 1-5 scale to 0-100 scores When you look at your report, you will notice that the scores are reported on a 0-100 scale, even though respondents
More information4.1 3T12 and 312 are immortalized cell lines with transforming potential:
DISCUSSION CHAPTER 4 4.1 3T12 and 312 are immortalized cell lines with transforming potential: Transformation of a normal cell with finite number of divisions into a tumorigenic cell of potentially infinite
More informationEasy Collection and Extraction of BioSamples Ahlstrom GenCollect Ahlstrom GenCollect Color
Easy Collection and Extraction of BioSamples Ahlstrom GenCollect Ahlstrom GenCollect Color Ahlstrom GenCollect and Ahlstrom GenCollect Color Collection of biosamples COST Storage at ambient temperature
More informationStatistics I for QBIC. Contents and Objectives. Chapters 1 7. Revised: August 2013
Statistics I for QBIC Text Book: Biostatistics, 10 th edition, by Daniel & Cross Contents and Objectives Chapters 1 7 Revised: August 2013 Chapter 1: Nature of Statistics (sections 1.1-1.6) Objectives
More informationInterpretation of Regulatory Guidance on Dodd Frank Investment Grade Due Diligence
Interpretation of Regulatory Guidance on Dodd Frank Investment Grade Due Diligence JC Brew, Senior Municipal Bond Analyst, Seifried & Brew LLC January 8, 2015 Seifried & Brew (S&B) provides relevant, dynamic
More informationOverview of Upstream and Downstream Processing of Biopharmaceuticals
Overview of Upstream and Downstream Processing of Biopharmaceuticals Ian Marison Professor of Bioprocess Engineering and Head of School of Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland
More information3 Chapter Three: Material and methods (clone creation, upstream and downstream process)
3 Chapter Three: Material and methods (clone creation, upstream and downstream process) 3.1 Model proteins and CHO cell cultures Two recombinant produced, CHO-cell-derived model-glycoproteins, a less glycosylated
More informationThe Public Policy Process W E E K 1 2 : T H E S C I E N C E O F T H E P O L I C Y P R O C E S S
The Public Policy Process W E E K 1 2 : T H E S C I E N C E O F T H E P O L I C Y P R O C E S S Why Study Public Policy Scientific Reasons To help us better understand the nature of political behavior
More informationISyE 2028 Basic Statistical Methods - Fall 2015 Bonus Project: Big Data Analytics Final Report: Time spent on social media
ISyE 2028 Basic Statistical Methods - Fall 2015 Bonus Project: Big Data Analytics Final Report: Time spent on social media Abstract: The growth of social media is astounding and part of that success was
More informationProgram Visualization for Programming Education Case of Jeliot 3
Program Visualization for Programming Education Case of Jeliot 3 Roman Bednarik, Andrés Moreno, Niko Myller Department of Computer Science University of Joensuu firstname.lastname@cs.joensuu.fi Abstract:
More informationbusiness statistics using Excel OXFORD UNIVERSITY PRESS Glyn Davis & Branko Pecar
business statistics using Excel Glyn Davis & Branko Pecar OXFORD UNIVERSITY PRESS Detailed contents Introduction to Microsoft Excel 2003 Overview Learning Objectives 1.1 Introduction to Microsoft Excel
More informationThe Big Data Paradigm Shift. Insight Through Automation
The Big Data Paradigm Shift Insight Through Automation Agenda The Problem Emcien s Solution: Algorithms solve data related business problems How Does the Technology Work? Case Studies 2013 Emcien, Inc.
More informationA Batch Computing Service for the Spot Market. Supreeth Subramanya, Tian Guo, Prateek Sharma, David Irwin, Prashant Shenoy
SpotOn: A Batch Computing Service for the Spot Market Supreeth Subramanya, Tian Guo, Prateek Sharma, David Irwin, Prashant Shenoy University of Massachusetts Amherst infrastructure cloud Cost vs. Availability
More informationIntroduction to Bioprocessing
Introduction to Bioprocessing Cambridge Healthtech Institute Peptalk Palm Springs, CA Presented by Susan Dana Jones and Sheila Magil BioProcess Technology Consultants www.bptc.com BioProcess Technology
More informationMEF Starter Nucleofector Kit
page 1 of 7 MEF Starter Nucleofector Kit for Mouse Embryonic Fibroblasts (MEF) MEF display significant phenotypic variations which depend on the strain, the genetic background of the mice they are isolated
More information